NEW YORK, April 2 – Pharmacopeia announced that it has merged its software subsidiaries into a new unit named Accelrys, which will begin operating as a separate unit on June 1.

The four subsidiaries, Molecular Simulations, Synopsys Scientific Systems, Oxford Molecular, and the Genetics Computer Group, had pro forma revenues of more than $90 million in 2000, or 76 percent of Pharmacopeia’s overall revenues of $119 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

NPR reports that with medical data being big business, some companies want to get patients involved.

The Asbury Park Press reports on the startup Genomic Prediction's test to determine an embryo's risk of disease.

In PNAS this week: optical mapping allows glimpse of structural variants, disease-linked GATA2 mutations boosts its protein activity, and more.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.